Reblozyl 75 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FM6JH
Awardee
Awarding agency
Obligated
$25,994

Award facts

Contract value 100% obligated
$25,993.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for Reblozyl 75 mg vials with a ceiling value of $25,993.83 under a firm fixed-price structure.

Place of performance is Conshohocken, PA. The order is scheduled for ultimate completion on April 2, 2026. No set-aside was used. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.

Quick answers

Who was awarded contract SPE2DR26FM6JH?

SPE2DR26FM6JH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 12, 2026.

How much is contract SPE2DR26FM6JH worth?

The government has obligated $25,994 on SPE2DR26FM6JH.

Is contract SPE2DR26FM6JH an order under another contract?

Yes. SPE2DR26FM6JH is a delivery order under SPE2DR25D3501, an indefinite delivery contract.

Was contract SPE2DR26FM6JH competed?

The extent of competition for SPE2DR26FM6JH was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award